Cowden disease, also known as multiple hamartoma syndrome, is an autos
omal dominant cancer syndrome with a high risk of breast and thyroid c
ancer, The gene involved has been localized to chromosome 10q22-23. Re
cently, the tumour suppressor gene PTEN/MMAC1, encoding a putative pro
tein tyrosine or dual-specificity phosphatase, was cloned from that re
gion and three mutations were detected in patients with Cowden disease
, We confirmed that the PTEN/MMAC1 gene is indeed the gene for Cowden
disease by a refined localization of the gene to the interval between
D10S1761 and D10S541, which contains the PTEN/MMAC1 gene and by mutati
on analysis in eight unrelated familial and 11 sporadic patients with
Cowden disease. Eight different mutations were detected in various reg
ions of the PTEN/MMAC1 gene, One mutation was detected twice, All dete
cted changes in the gene can be predicted to have a very deleterious e
ffect on the putative protein, Five of the nine patients have a mutati
on in exon 5 coding for the putative active site and flanking amino ac
ids. Evaluation of the clinical data of the patients in which a mutati
on could be detected gives no clear indications for a correlation betw
een the genotype and phenotype, In 10 patients no mutation could be de
tected so far, In support of the linkage data, no evidence has emerged
from the phenotype of these patients suggestive for genetic heterogen
eity.